NuCana PLCHere is the public summary page for NuCana PLC. Please login to see the complete information for NuCana PLC including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how NuCana PLC stacks up relative to its peers. |
| Darwin Score | -16 |
| Ticker | NCNA |
| Latest Price | 0.06 USD as of close on 25-Jul-2025 |
| 3 Month price range | 0.03 to 1.10 USD |
| Market Capitalisation | 20.61Mn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase 1b/2 study in patients with metastatic colorectal cancer; Phase 2 clinical trial for the second-line treatment of patients with advanced colorectal cancer; and Phase 1 modular clinical trial for patients with advanced solid tumors and lung cancer. The company is also developing NUC-7738, a ProTide transformation of 3'-deoxyadenosine, which is in the Phase 2 part of a Phase 1/2 clinical trial for patients with advanced solid tumors. The company has an assignment, license, and collaboration agreement with Cardiff ProTides Ltd to discover, drug design, and in vitro screen purine and pyrimidine-based nucleosides as potential drug candidates. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is based in Edinburgh, the United Kingdom. See More ... |
| Company URL | https://www.nucana.com |
| See Darwins Full Analysis for NuCana PLC |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for NuCana PLC. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +3 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | 0 |
| Flow | Institutional, Fund and Insider buying and selling. | -2 |
| Models | Forecast models. | -17 |
Alerts
There are 13 live alerts for NuCana PLC.
- Divergence: Px Down & OBV Up last 10 days. This alert has occurred 153 times over the last last year. The average forward returns are 7.3% over 5 days, 5.8% over 10 days, 0.9% over 15 days and -4.7% over 20 days. (Positive)
- Divergence: Px Down & 5d RSI Up last 10 days. This alert has occurred 60 times over the last last year. The average forward returns are 10.6% over 5 days, 9.9% over 10 days, 3.7% over 15 days and 11.4% over 20 days. (Positive)
- Overbought - The 5 day RSI is +90.9. (Negative)
- Oversold - The 5 month RSI is +7.2. (Positive)
- Oversold - The 15 month RSI is +17.9. (Positive)
- Divergence: Px Down & OBV Up last 65 days. This alert has occurred 220 times over the last last year. The average forward returns are 3.9% over 5 days, 4.2% over 10 days, -0.0% over 15 days and -4.0% over 20 days. (Positive)
- Cross Over (Up): 20dma . This alert has occurred 11 times over the last last year. The average forward returns are -0.6% over 5 days, -23.3% over 10 days, -38.5% over 15 days and -35.1% over 20 days. (Positive)
- Divergence: Px Down & 15d RSI Up last 20 days. This alert has occurred 72 times over the last last year. The average forward returns are -1.0% over 5 days, 5.7% over 10 days, -2.1% over 15 days and -13.5% over 20 days. (Positive)
- Divergence: Px Down & OBV Up last 20 days. This alert has occurred 177 times over the last last year. The average forward returns are 1.9% over 5 days, 0.8% over 10 days, -1.3% over 15 days and -5.1% over 20 days. (Positive)
- High Volume 2x 65dma. This alert has occurred 47 times over the last last year. The average forward returns are -4.9% over 5 days, -20.7% over 10 days, -3.4% over 15 days and 19.0% over 20 days. (Positive)
- Divergence: Px Down & 30d RSI Up last 20 days. This alert has occurred 62 times over the last last year. The average forward returns are 0.5% over 5 days, -1.5% over 10 days, -10.2% over 15 days and -19.6% over 20 days. (Positive)
- 5d RSI Overbought. This alert has occurred 31 times over the last last year. The average forward returns are -9.3% over 5 days, -24.1% over 10 days, -34.3% over 15 days and -33.1% over 20 days. (Positive)
- High Volume 2x 130dma. This alert has occurred 55 times over the last last year. The average forward returns are 1.8% over 5 days, 9.9% over 10 days, 16.2% over 15 days and 25.4% over 20 days. (Positive)
Peer Comparison
There are 27 peers of NuCana PLC.
Share 
